Alpha Teknova, Inc.
TKNO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001850902
No open-market purchases or sales by Alpha Teknova, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $51.7M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Alpha Teknova, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +3 vs. Q3 2023
- Shares held
- 5.62M
- +415.8K (+8.0%) vs. Q3 2023
- Total value
- $21.0M
- +$6.47M (+44.6%) vs. Q3 2023
- New holders
- 5
- 12 more added
- Sold out
- 2
- 9 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TKNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $51.7M |
| Q1 2026 | 78 | $22.1M |
| Q4 2025 | 70 | $26.6M |
| Q3 2025 | 67 | $45.9M |
| Q2 2025 | 68 | $37.6M |
| Q1 2025 | 65 | $32.0M |
| Q4 2024 | 47 | $53.2M |
| Q3 2024 | 32 | $24.9M |
| Q2 2024 | 28 | $8.03M |
| Q1 2024 | 31 | $15.6M |
| Q4 2023 | 31 | $21.0M |
| Q3 2023 | 28 | $14.5M |
| Q2 2023 | 31 | $12.0M |
| Q1 2023 | 44 | $16.3M |
| Q4 2022 | 47 | $30.2M |
| Q3 2022 | 54 | $21.3M |
| Q2 2022 | 52 | $58.1M |
| Q1 2022 | 51 | $95.3M |
| Q4 2021 | 52 | $146.3M |
| Q3 2021 | 52 | $178.0M |
| Q2 2021 | 50 | $153.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Alpha Teknova, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 122 | $0 | 0.00% | +95+351.9% | Added |
| FMR LLC | 46 | $172 | 0.00% | −103−69.1% | Reduced |
| JPMorgan Chase & Co | 83 | $310 | 0.00% | −1,188−93.5% | Reduced |
| Wells Fargo & Company | 194 | $724 | 0.00% | +98+102.1% | Added |
| UBS Group AG | 2,093 | $7.81K | 0.00% | −1,239−37.2% | Reduced |
| Citigroup Inc | 3,038 | $11.3K | 0.00% | +3,035+101,166.7% | Added |
| Tower Research Capital LLC (TRC) | 3,118 | $11.6K | 0.00% | −872−21.9% | Reduced |
| Boothbay Fund Management, LLC | 10,299 | $38.4K | 0.00% | +10,299 | New |
| Jane Street Group, LLC | 10,432 | $38.9K | 0.00% | +10,432 | New |
| Qube Research & Technologies Ltd | 10,765 | $40.2K | 0.00% | +9,625+844.3% | Added |
| Brown Advisory Inc | 11,133 | $41.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,945 | $81.9K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 27,543 | $102.7K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 30,283 | $113.0K | 0.00% | +13,750+83.2% | Added |
| BlackRock Inc. | 37,535 | $140.0K | 0.00% | −3,845−9.3% | Reduced |
| 683 Capital Management, LLC | 40,092 | $149.5K | 0.01% | +40,092 | New |
| Fielder Capital Group LLC | 41,849 | $156.1K | 0.09% | +41,849 | New |
| Schonfeld Strategic Advisors LLC | 49,200 | $183.5K | 0.00% | +3,100+6.7% | Added |
| Susquehanna International Group, LLP | 49,858 | $186.0K | 0.00% | +49,858 | New |
| Premier Fund Managers Ltd | 58,830 | $222.0K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 70,000 | $261.1K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 103,884 | $387.5K | 0.00% | +102,219+6,139.3% | Added |
| Geode Capital Management, LLC | 145,880 | $544.2K | 0.00% | +71,984+97.4% | Added |
| Redmile Group, LLC | 161,005 | $600.5K | 0.02% | −123,559−43.4% | Reduced |
| Bank of America Corp | 217,918 | $812.8K | 0.00% | +217,917+21,791,700.0% | Added |
| Conestoga Capital Advisors, LLC | 247,529 | $923.3K | 0.01% | +9,800+4.1% | Added |
| Parkman Healthcare Partners LLC | 282,236 | $1.05M | 0.15% | +48,490+20.7% | Added |
| Vanguard Group Inc | 394,325 | $1.47M | 0.00% | −8,055−2.0% | Reduced |
| Platinum Investment Management Ltd | 736,540 | $2.75M | 0.11% | −97,989−11.7% | Reduced |
| Balyasny Asset Management LLC | 1,045,669 | $3.90M | 0.01% | −20,803−2.0% | Reduced |
| Millennium Management LLC | 1,810,503 | $6.75M | 0.01% | +45,933+2.6% | Added |
| Authentikos Wealth Advisory, LLC | 0 | $0 | 0.00% | −357−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −4,808−100.0% | Sold out |